OCC 1.10% 46.0¢ orthocell limited

Ann: Third Revenue Generating Product to be Launched in SmrtGraft, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 773 Posts.
    lightbulb Created with Sketch. 220
    Don't really like quoting addressable market sizes although it's done frequently. If they were real about expectations they should realistically analyse how much they might penetrate and give a reasonable time for growth. If they can make $5-10 million they should get valued at least 50c-$1 based on 20 xPE and having about 200 million shares on issue. (I think). So I'll wait to see if I increase my holding based on the financials not the potential. I think the sector has been hit over recent times partly because investors have had enough of potential and will wait for some financial strength before investing. Still think OCC is in a good place relative to many others but the valuation will only increase with more significant revenue. I also think they need to retain as much margin as possible so using third parties to distribute doesn't always bode well but at this stage I get the tie up for striate. GLTA
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.